Glucagon
- Generic Name
- Glucagon
- Brand Names
- Baqsimi, Glucagen, Gvoke, Ogluo
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 16941-32-5
- Unique Ingredient Identifier
- 76LA80IG2G
- Background
Glucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia. Glucagon raises blood sugar through activation of hepatic glucagon receptors, stimulating glycogenolysis and the release of glucose.
...
- Indication
Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.
- Associated Conditions
- Severe Hypoglycemia
- Associated Therapies
- -
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
- Conditions
- Interventions
- First Posted Date
- 2008-11-25
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Legacy Health System
- Target Recruit Count
- 14
- Registration Number
- NCT00797823
- Locations
- 🇺🇸
Legacy Research, Portland, Oregon, United States
Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
- Conditions
- First Posted Date
- 2007-02-13
- Last Posted Date
- 2009-05-28
- Lead Sponsor
- Shaare Zedek Medical Center
- Registration Number
- NCT00434772
- Locations
- 🇮🇱
Share Zedek Medical Center, Jerusalem, Israel
Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
- Conditions
- First Posted Date
- 2000-06-05
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 96
- Registration Number
- NCT00005889
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.